Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

EURL PHARMACIE SAINT EXUPERY : revenue, balance sheet and financial ratios

EURL PHARMACIE SAINT EXUPERY is a French company founded 25 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BISCARROSSE (40600), this company of category PME shows in 2024 a net income positive of 166 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - EURL PHARMACIE SAINT EXUPERY (SIREN 530959006)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income 166 394 € 155 595 € 151 484 € 117 889 € 102 033 € 108 419 € 109 028 € 133 017 € 130 135 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, EURL PHARMACIE SAINT EXUPERY generates positive net income of 166 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 130 k€ -> 166 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

166 394 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 35%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 67%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

35.287%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

67.011%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

2.6%

Solvency indicators evolution
EURL PHARMACIE SAINT EXUPERY

Sector positioning

Debt ratio
35.29 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good -11 pts over 3 years

In 2024, the debt ratio of EURL PHARMACIE SAINT EXUPERY (35.29) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
67.01% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good +14 pts over 3 years

In 2024, the financial autonomy of EURL PHARMACIE SAINT EXUPERY (67.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 181.31. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

181.311

Liquidity indicators evolution
EURL PHARMACIE SAINT EXUPERY

Sector positioning

Liquidity ratio
181.31 2024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average +16 pts over 3 years

In 2024, the liquidity ratio of EURL PHARMACIE SAINT EXUPERY (181.31) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of EURL PHARMACIE SAINT EXUPERY in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of EURL PHARMACIE SAINT EXUPERY is estimated at 2 322 983 € (range 1 617 688€ - 3 475 315€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1617k€ 2322k€ 3475k€
2 322 983 € Range: 1 617 688€ - 3 475 315€
NAF 5 année 2024

Valuation method used

Net Income Multiple
166 394 € × 14.0x = 2 322 983 €
Range: 1 617 689€ - 3 475 316€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare EURL PHARMACIE SAINT EXUPERY with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about EURL PHARMACIE SAINT EXUPERY

What is the revenue of EURL PHARMACIE SAINT EXUPERY ?

The revenue of EURL PHARMACIE SAINT EXUPERY is not publicly disclosed (confidential accounts filed with INPI).

Is EURL PHARMACIE SAINT EXUPERY profitable?

Yes, EURL PHARMACIE SAINT EXUPERY generated a net profit of 166 k€ in 2024.

Where is the headquarters of EURL PHARMACIE SAINT EXUPERY ?

The headquarters of EURL PHARMACIE SAINT EXUPERY is located in BISCARROSSE (40600), in the department Landes.

Where to find the tax return of EURL PHARMACIE SAINT EXUPERY ?

The tax return of EURL PHARMACIE SAINT EXUPERY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does EURL PHARMACIE SAINT EXUPERY operate?

EURL PHARMACIE SAINT EXUPERY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.